{
  "meta": {
    "title": "Pituitary_Hypothalamic_System",
    "url": "https://brainandscalpel.vercel.app/pituitary-hypothalamic-system-747f8c87.html",
    "scrapedAt": "2025-11-29T18:33:55.225Z"
  },
  "questions": [
    {
      "id": 3733,
      "choices": [
        {
          "id": 14911,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is effective orally.</span></span></span></p>"
        },
        {
          "id": 14912,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used for the treatment of acromegaly.</span></span></span></p>"
        },
        {
          "id": 14913,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be used for the management of secretory Diarrhea.</span></span></span></p>"
        },
        {
          "id": 14914,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It can be used in portal hypertension.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following statements about octreotide are true except.</span></span></span></p>",
      "unique_key": "Q6616879",
      "question_audio": null,
      "question_video": null,
      "map_id": 36090,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. It is effective orally.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is effective orally</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is<strong> not true</strong> about<strong> octreotide</strong>. <strong>Octreotide is a synthetic analogue of somatostatin </strong>and its therapeutic effects are primarily through <strong>parenteral route</strong>s, such as <strong>subcutaneous or intravenous injections</strong>. The<strong> oral bioavailability of octreotide is</strong> <strong>extremely low</strong> due to its<strong> rapid degradation</strong> in the g<strong>astrointestinal tract</strong> and its <strong>inability to be effectively absorbed </strong>when taken by <strong>mouth</strong>. Therefore, it is<strong> not used or effective in oral form for clinical purposes.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <em>Drugs ending with <strong>&lsquo;tide&rsquo; are peptides</strong> and are <strong>not effective orally </strong></em></span><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>because</strong>, the <strong>presence of peptidases (like pepsin, trypsin </strong>etc.) in the GIT&nbsp; will <strong>make these inactive.</strong></span></em></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is used for the treatment of acromegaly</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This statement is <strong>true</strong>. <strong>Octreotide</strong> is used in the<strong> treatment of acromegaly,</strong> a condition characterized by<strong> excessive growth hormone production, leading to enlarged</strong> features. <strong>Octreotide </strong>helps by <strong>inhibiting</strong> <strong>growth hormone secretion.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It can be used for the management of secretory Diarrhea</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is also<strong> true.</strong> Octreotide can manage <strong>secretory diarrhea,</strong> including that<strong> caused by certain tumors (like carcinoid tumors or VIPomas),</strong> by <strong>inhibiting the secretion</strong> of various gastrointestinal <strong>hormones and substances.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It can be used in portal hypertension</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>True.</strong> Octreotide is used in the management of <strong>portal hypertension, </strong>particularly to <strong>control variceal bleeding, </strong>by <strong>reducing blood flow</strong> to the<strong> gastrointestinal tract</strong> and<strong> lowering portal vein pressure.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While<strong> octreotide</strong> is a valuable medication in the management of <strong>acromegaly, secretory diarrhea, and portal hypertension,</strong> it must be administered through<strong> parenteral routes</strong> due to its<strong> poor oral bioavailability. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - You can remember this fact from the name of the drug. If the <strong>name of a drug ends with &lsquo;tide&rsquo;,</strong> it is a <strong>peptide and peptides</strong> <strong>cannot be given orally</strong> because, the <strong>presence of peptidases (like pepsin, trypsin etc.)</strong> will make these <strong>inactive.</strong></span></span></span></p>",
      "correct_choice_id": 14911,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3725,
      "choices": [
        {
          "id": 14879,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sumatriptan</span></span></span></p>"
        },
        {
          "id": 14880,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bromocriptine</span></span></span></p>"
        },
        {
          "id": 14881,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ergotamine</span></span></span></p>"
        },
        {
          "id": 14882,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allopurinol</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 22-year-old female, Neeta, presented to you with complaints of headache and vomiting for 2 months. She has amenorrhea, but the urine pregnancy test is negative. She also complained of secretion of milk from the breasts. A provisional diagnosis of hyperprolactinemia was made, and MRI was suggested. MRI confirmed the presence of a large pituitary adenoma. Neeta was advised surgery; however, she is not willing to undergo surgery. Which of the following medications is most likely to be prescribed to control her symptoms?</span></span></span></p>",
      "unique_key": "Q1682011",
      "question_audio": null,
      "question_video": null,
      "map_id": 36085,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Bromocriptine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bromocriptine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a<strong> dopamine agonist</strong> that is effective in the treatment of <strong>hyperprolactinemia, </strong>which is characterized by <strong>elevated</strong> <strong>levels of prolactin </strong>leading to symptoms such as<strong> amenorrhea, galactorrhea (secretion of milk from the breasts), headache, </strong>and in some cases,<strong> vision problems </strong>due to <strong>pituitary adenomas</strong>. Bromocriptine works by <strong>binding to dopamine D2 receptors </strong>in the pituitary gland, which<strong> inhibits the secretion of prolactin</strong>. In addition to <strong>lowering prolactin levels</strong>, bromocriptine can also <strong>reduce the size of</strong> <strong>prolactin-secreting pituitary adenomas</strong>, thus <strong>helping to alleviate </strong>symptoms associated with the<strong> tumor</strong>, including <strong>headaches and</strong> <strong>vision issues.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sumatriptan</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Sumatriptan is a medication<strong> used to treat acute migraine headaches</strong>. It is a <strong>serotonin receptor agonist</strong> that causes<strong> vasoconstriction of cranial blood vessels.</strong> It is<strong> not </strong>used in the treatment of<strong> hyperprolactinemia or pituitary adenomas.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ergotamine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ergotamine is<strong> used for </strong>the treatment of <strong>migraine headaches</strong>. It is an <strong>ergot alkaloid </strong>that causes <strong>vasoconstriction. </strong>It<strong> does not</strong> reduce<strong> prolactin levels or treat pituitary adenomas.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Allopurinol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Allopurinol is used to <strong>decrease high blood uric acid levels</strong>, as seen in <strong>gout </strong>and certain types of <strong>kidney stones. </strong>It is not relevant to the treatment of hyperprolactinemia or pituitary adenomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bromocriptine</strong> is the appropriate pharmacological treatment for<strong> hyperprolactinemia </strong>caused by a<strong> pituitary adenoma</strong>, especially when surgery is not an option. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bromocriptine</strong> is the preferred<strong> choice</strong> due to its dual role in<strong> reducing prolactin levels and potentially decreasing the size of the</strong> <strong>adenoma</strong>, thus addressing<strong> both </strong>the <strong>hormonal imbalance and its physical cause.</strong> </span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></span></span></p>",
      "correct_choice_id": 14880,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3729,
      "choices": [
        {
          "id": 14895,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucagonoma</span></span></span></p>"
        },
        {
          "id": 14896,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulinoma</span></span></span></p>"
        },
        {
          "id": 14897,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoid syndrome</span></span></span></p>"
        },
        {
          "id": 14898,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glioma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Octreotide is used in all except? </span></span></span></p>",
      "unique_key": "Q5738935",
      "question_audio": null,
      "question_video": null,
      "map_id": 36087,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Glioma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glioma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> refers to a type of<strong> tumor</strong> that arises from<strong> glial cells</strong> in <strong>the brain or spinal cord. Octreotide,</strong> a<strong> somatostatin analogue, </strong>is <strong>not</strong> used in the treatment of <strong>gliomas. Octreotide&#39;</strong>s mechanism of action involves <strong>mimicking natural somatostatin</strong> to<strong> inhibit the secretion</strong> of several hormones, including <strong>growth hormone, glucagon, and insulin, </strong>making it useful in conditions related to<strong> excessive</strong> <strong>hormone secretion,</strong> but i<strong>t does not </strong>have a therapeutic role in the treatment of <strong>gliomas,</strong> which are <strong>primary brain or spinal cord</strong> <strong>tumors</strong>. The <strong>drug of choice</strong> for <strong>glioma is temozolomide.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Glucagonoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Octreotide</strong> is used in the management of <strong>glucagonoma,</strong> a rare type of <strong>pancreatic neuroendocrine tumor</strong> that <strong>secretes excessive amounts of glucagon. </strong>Octreotide helps in controlling symptoms by <strong>inhibiting glucagon secretion.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Insulinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although <strong>insulinomas produce excessive insulin,</strong> <strong>octreotide</strong> can sometimes be used in the management of these tumors to<strong> help control hypoglycemia</strong>, particularly in patients with <strong>metastatic disease </strong>or those who are <strong>not candidates for</strong> <strong>surgery.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Carcinoid syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Octreotide </strong>is effectively used in the treatment of<strong> carcinoid syndrome</strong>, which is characterized by <strong>flushing, diarrhea, and wheezing </strong>due to the<strong> secretion of serotonin </strong>and other<strong> vasoactive substances</strong> by <strong>carcinoid tumors.</strong> <strong>Octreotide</strong> helps in reducing these symptoms by <strong>inhibiting the secretion of these substances.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uses of Octreotide</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture8.jpg\" style=\"height:228px; width:1000px\" /></p>",
      "correct_choice_id": 14898,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3693,
      "choices": [
        {
          "id": 14751,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anterior thigh</span></span></span></p>"
        },
        {
          "id": 14752,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lateral thigh</span></span></span></p>"
        },
        {
          "id": 14753,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upper arm</span></span></p>"
        },
        {
          "id": 14754,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Around umbilicus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following sites is least commonly preferred for insulin injection? </span></span></span></p>",
      "unique_key": "Q8388063",
      "question_audio": null,
      "question_video": null,
      "map_id": 36084,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Around umbilicus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sites of Insulin Injection</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Insulin </strong>usually is <strong>injected</strong> into the <strong>subcutaneous tissues of the abdomen, buttock, anterior and lateral thigh or upper arm.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Absorption </strong>is variable in the area<strong> around the umbilicus, </strong>therefore this site is not recommended for insulin administration.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Absorption</strong> is usually <strong>most rapid from the abdominal wall,</strong> followed by the<strong> arm, buttock, and thigh.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If a patient is willing to<strong> inject into the abdomen, injections</strong> can be <strong>rotated throughout the entire area, </strong>thereby <strong>eliminating the injection site </strong>as a cause of variability in the <strong>rate of absorption.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>abdomen currently</strong> is the preferred <strong>site of injection</strong> because<strong> insulin is absorbed 20&ndash;30% faster from that site</strong> than <strong>from the arm.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Rotation of insulin injection</strong> sites traditionally has been advocated to <strong>avoid lipohypertrophy or lipoatrophy, </strong>although these conditions are i<strong>nfrequent with current preparations of insulin.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A. Anterior thigh </strong>and<strong> B. Lateral thigh C. Upper arm:</strong> These areas are <strong>common for insulin injections</strong> and provide <strong>consistent</strong> <strong>absorption</strong>, although generally <strong>slower </strong>compared to the <strong>abdominal wall.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SITES OF INSULIN INJECTION</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture5.jpg\" style=\"height:385px; width:600px\" /></p>",
      "correct_choice_id": 14754,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3658,
      "choices": [
        {
          "id": 14611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypotensive state</span></span></span></p>"
        },
        {
          "id": 14612,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcoholics</span></span></span></p>"
        },
        {
          "id": 14613,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal failure</span></span></span></p>"
        },
        {
          "id": 14614,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following are contraindications for the use of metformin except?</span></span></span></p>",
      "unique_key": "Q4570542",
      "question_audio": null,
      "question_video": null,
      "map_id": 36082,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Hypokalemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Metformin is a biguanide </strong>class of antidiabetic medication primarily used for the management of<strong> Type 2 diabetes mellitus</strong>. It works by <strong>decreasing hepatic glucose production </strong>and <strong>improving insulin sensitivity. </strong>It can <strong>increase risk of lactic acidosis </strong>particularly in patients with<strong> liver disease, renal disease </strong>and those<strong> pre-disposed to hypoxia</strong>. While it has <strong>several contraindications, hypokalemia (low potassium levels) is not </strong>directly related to its<strong> use or its mechanism of action</strong>. Therefore, the presence of <strong>hypokalemia does not preclude the use of metformin</strong>, provided that the<strong> hypokalemia itself is managed appropriately.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hypotensive state</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While <strong>not a direct contraindication, </strong>caution is advised in conditions that may <strong>predispose patients to hypotension</strong>, as <strong>low perfusion </strong>may<strong> increase the risk of metformin </strong>induced <strong>lactic acidosis.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Alcoholics</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: <strong>Chronic and excessive alcohol </strong>consumption is a <strong>contraindication for metformin </strong>use due to the<strong> increased risk of lactic acidosis</strong>, especially in cases of<strong> hepatic impairment and acute alcohol intoxication.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Renal failure</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Renal failure or significant <strong>renal impairment is a contraindication </strong>for the use of<strong> metformin </strong>due to the <strong>increased risk of accumulating metformin </strong>and subsequent<strong> lactic acidosis</strong>. Latest guidelines regarding use of<strong> metformin in renal dysfunction </strong>include:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture1.jpg\" style=\"height:229px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk factors for metformin induced lactic acidosis</span></em></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatic failure </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal failure </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcoholics</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolic acidosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elderly</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conditions predisposing to hypoxia (Shock, CHF, Severe anemia, Major surgery etc.)</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mnemonic:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">MET: MET</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">abolic</span><strong> </strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">acidosis</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">F: F</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ailure (Liver and Renal failure)</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">O R MIN: O</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">xygen&nbsp;</span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">R</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">eaching the tissues is&nbsp;</span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">MIN</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">imum (means hypoxia causing conditions)</span></span></span></p>",
      "correct_choice_id": 14614,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3957,
      "choices": [
        {
          "id": 15807,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raloxifene</span></span></span></p>"
        },
        {
          "id": 15808,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bisphosphonates</span></span></span></p>"
        },
        {
          "id": 15809,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Teriparatide</span></span></span></p>"
        },
        {
          "id": 15810,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Denosumab</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given figure shows the mechanism of action of Drug Y in treatment of osteoporosis. Which of the following best represents drug Y?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture16.jpg\" style=\"height:381px; width:600px\" /></p>",
      "unique_key": "Q9213385",
      "question_audio": null,
      "question_video": null,
      "map_id": 36089,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Denosumab</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The figure illustrates that <strong>Drug Y inhibits the binding of RANKL to RANK, </strong>which is crucial for the <strong>formation, function, and survival of</strong> <strong>osteoclasts. Denosumab is a monoclonal antibody </strong>designed to <strong>target RANKL</strong>, thereby preventing it from <strong>activating RANK on</strong> <strong>osteoclasts and their precursors</strong>. This<strong> inhibition</strong> effectively reduces the<strong> formation and activity of osteoclasts,</strong> leading to a<strong> decrease in bone resorption.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Raloxifene:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect&nbsp;</strong>for this mechanism.<strong> Raloxifene is a selective estrogen receptor modulator (SERM) </strong>that mimics <strong>estrogen&#39;s bone-protective effect</strong>s by <strong>reducing osteoclast activity,</strong> but it<strong> does not</strong> work by targeting the<strong> RANKL-RANK interaction.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Bisphosphonates:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also<strong> incorrect. </strong>Bisphosphonates<strong> inhibit</strong> <strong>osteoclast-mediated bone resorption</strong> by inducing <strong>osteoclast</strong> <strong>apoptosis </strong>and interfering with the<strong> mevalonate pathway</strong>, not by RANKL inhibition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Teriparatide:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Incorrect&nbsp;</strong>for this illustration. <strong>Teriparatide,</strong> a recombinant form of <strong>parathyroid hormone</strong>, primarily works by <strong>stimulating osteoblasts</strong> to promote <strong>bone formation rather than inhibiting osteoclasts.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Denosumab</strong> is used in the treatment of <strong>osteoporosis by targeting the RANKL-RANK interaction</strong>, effectively <strong>inhibiting osteoclast</strong> formation and activity, thus <strong>decreasing bone resorption.</strong></span></span></span></p>",
      "correct_choice_id": 15810,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3668,
      "choices": [
        {
          "id": 14651,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It belongs to sulfonylurea class of drugs.</span></span></span></p>"
        },
        {
          "id": 14652,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is not well absorbed on oral administration.</span></span></span></p>"
        },
        {
          "id": 14653,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used to control sleep time hyperglycemia.</span></span></span></p>"
        },
        {
          "id": 14654,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It should be avoided in patients with liver disease.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old patient with Type 2 diabetes mellitus is being evaluated for potential adjustments to their glucose-lowering therapy. The patient&#39;s current regimen includes metformin and a once-daily basal insulin. Despite these treatments, the patient&#39;s glycemic control remains suboptimal, with particular difficulty managing postprandial blood sugar spikes. The patient has a history of non-alcoholic fatty liver disease but normal liver function tests. The healthcare provider is considering adding repaglinide for treatment of this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is true about repaglinide?</span></span></span></p>",
      "unique_key": "Q4909937",
      "question_audio": null,
      "question_video": null,
      "map_id": 36088,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. It should be avoided in patients with liver disease.&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Repaglinide </strong>is a medication that should be used with<strong> caution in patients with liver disease</strong>. It is <strong>metabolized by the liver</strong>, and its use in patients with <strong>impaired liver function </strong>could <strong>lead to an increased risk of hypoglycemia </strong>due to <strong>decreased drug clearance</strong>. Although <strong>not an absolute contraindication,</strong> careful consideration, monitoring, and possibly <strong>dose adjustments </strong>are recommended when prescribing<strong> repaglinide to patients with liver disease</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It belongs to the sulfonylurea class of drugs.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>incorrect. Repaglinide </strong>is a<strong> meglitinide</strong>, <strong>not a sulfonylurea</strong>. Both classes of drugs <strong>stimulate insulin secretion from the pancreas </strong>but through slightly different mechanisms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is not well absorbed on oral administration.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>incorrect. Repaglinide </strong>is<strong> well absorbed </strong>when taken <strong>orally</strong>, which is why it is effective in <strong>controlling postprandial (after meal) blood glucose levels</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It is used to control sleep time hyperglycemia.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> incorrect. Repaglinide </strong>is primarily used to control <strong>postprandial hyperglycemia</strong>, not sleep time hyperglycemia. It has a <strong>rapid onset and short duration of action</strong>, making it suitable for taking<strong> before meals to manage blood sugar spikes after eating</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Repaglinide </strong>is a <strong>meglitinide </strong>class medication used for the management of<strong> postprandial hyperglycemia </strong>in patients with<strong> Type 2 diabetes</strong>. It is important to understand that while <strong>repaglinide </strong>is effective in <strong>controlling blood glucose levels after meals</strong>, caution is advised when prescribing it to patients with<strong> liver disease </strong>due to potential <strong>alterations in drug metabolism and clearance.</strong></span></span></p>",
      "correct_choice_id": 14654,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3736,
      "choices": [
        {
          "id": 14923,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contraindicated in hyperthyroidism.</span></span></span></p>"
        },
        {
          "id": 14924,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes iodism.</span></span></span></p>"
        },
        {
          "id": 14925,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits the release of thyroxine.</span></span></span></p>"
        },
        {
          "id": 14926,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibits the synthesis of iodo thyroxine and iodothyronine.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about iodine is false?</span></span></span></p>",
      "unique_key": "Q2268059",
      "question_audio": null,
      "question_video": null,
      "map_id": 36092,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Contraindicated in hyperthyroidism.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement <strong>&quot;Contraindicated in hyperthyroidism&quot;</strong> is <strong>false regarding iodine</strong>. Iodine, particularly in the <strong>form of potassium iodide</strong>, can be used in certain<strong> hyperthyroidism</strong> contexts, such as preparing a patient with <strong>hyperthyroidism for thyroidectomy </strong>or treating <strong>thyroid storm.</strong> Iodine can <strong>temporarily inhibit the release of thyroid hormones</strong> through the <strong>Wolff-Chaikoff effect</strong>, making it useful in these scenarios. Thus, it is<strong> not universally contraindicated in hyperthyroidism</strong>; instead, its use is specific and strategic in the management of the condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Causes iodism</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This statement is true. Iodism refers to a set of symptoms including metallic taste, burning mouth and throat, sore teeth and gums, symptoms of a head cold, and sometimes stomach upset and diarrhea. These symptoms can occur with the use of iodine supplements or drugs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Inhibits the release of thyroxine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: True. High doses of iodine can temporarily inhibit the release of thyroxine (T4) and triiodothyronine (T3) from the thyroid gland, a phenomenon known as the Wolff-Chaikoff effect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Inhibits the synthesis of iodo thyroxine and iodothyronine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: True. Iodine in large doses can inhibit the synthesis of thyroid hormones (thyroxine [T4] and triiodothyronine [T3]) by interfering with the iodination of tyrosyl residues in thyroglobulin and the coupling of iodotyrosyl residues to form iodothyronines.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iodine is not universally contraindicated in hyperthyroidism. It can be used strategically to manage certain aspects of the condition, such as preoperative preparation and acute crisis management, through its temporary inhibitory effects on thyroid hormone synthesis and release.</span></span></p>",
      "correct_choice_id": 14923,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3741,
      "choices": [
        {
          "id": 14943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT 2 inhibitor</span></span></span></p>"
        },
        {
          "id": 14944,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">DPP IV inhibitor</span></span></span></p>"
        },
        {
          "id": 14945,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meglitinide analogues</span></span></span></p>"
        },
        {
          "id": 14946,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLP1 agonist</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following antidiabetic drugs act by release of insulin except?</span></span></span></p>",
      "unique_key": "Q6794318",
      "question_audio": null,
      "question_video": null,
      "map_id": 36093,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. SGLT 2 inhibitor </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT2 inhibitors like canagliflozin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> act by a mechanism that<strong> does not</strong> involve the<strong> release of insulin.</strong> <strong>Sodium-glucose cotransporter 2</strong> <strong>(SGLT2) inhibitors</strong> work by <strong>blocking the SGLT2 protein in the kidneys, </strong>which leads to the<strong> reduction of glucose reabsorption </strong>in the <strong>renal tubules, </strong>thereby<strong> increasing glucose excretion in the urine</strong>. This mechanism<strong> lowers blood glucose levels independently of</strong> <strong>insulin secretion or action, </strong>making it<strong> distinct from</strong> the <strong>other options</strong> listed, which are associated with<strong> insulin release or its effects.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. DPP-IV inhibitor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DPP-IV inhibitors like <strong>sitagliptin work by inhibiting the enzyme dipeptidyl peptidase-4, </strong>which is responsible for the <strong>degradation of incretin hormones.</strong> By<strong> inhibiting this enzyme, </strong>the <strong>levels of incretin hormones (such as GLP-1) are</strong> <strong>increased, </strong>which in turn <strong>stimulates the release of insulin in a glucose-dependent manner.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Meglitinide analogues</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Meglitinide analogues like<strong> repaglinide stimulate the pancreas to release more insulin</strong>. They<strong> bind</strong> to <strong>specific channels on pancreatic beta cells, </strong>causing these<strong> cells to release insulin,</strong> thereby<strong> reducing blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. GLP-1 agonist</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: GLP-1 agonists like <strong>exenatide mimic </strong>the action of the <strong>incretin hormone GLP-1, </strong>which <strong>increases insulin</strong> <strong>secretion</strong> from the pancreas in a<strong> glucose-dependent manner. </strong>Additionally,<strong> GLP-1 agonists reduce glucagon secretion and slow</strong> <strong>gastric emptying.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CLASSIFICATION OF ANTI-DIABETIC DRUGS </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/02/picture9.jpg\" style=\"height:827px; width:1000px\" /></p>",
      "correct_choice_id": 14943,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4237,
      "choices": [
        {
          "id": 16925,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the only approved inhalational insulin.</span></span></span></p>"
        },
        {
          "id": 16926,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is used before meals to control postprandial hyperglycemia.</span></span></span></p>"
        },
        {
          "id": 16927,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is indicated as a replacement for injectable insulin.</span></span></span></p>"
        },
        {
          "id": 16928,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It should be avoided in chronic smokers.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 43-year-old man with type 2 diabetes mellitus is interested in alternative methods of insulin administration because he has difficulty with injections due to a significant needle phobia. He has heard about an inhaled form of insulin and asks about its use and any potential limitations. Which of the following statements about inhaled insulin (Afrezza) is incorrect? </span></span></span></p>",
      "unique_key": "Q2906803",
      "question_audio": null,
      "question_video": null,
      "map_id": 36086,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Indicated as a replacement for injectable insulin.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Afrezza,</strong> an <strong>inhaled insulin</strong>, is <strong>not </strong>typically indicated as a<strong> complete replacement for injectable insulin</strong>. While <strong>Afrezza </strong>can be used to manage<strong> postprandial hyperglycemia in adults with diabetes</strong> and is taken <strong>before meals, i</strong>t is usually used in <strong>conjunction</strong> with<strong> long-acting insulin </strong>in patients with <strong>type 1 diabetes</strong> and is<strong> not </strong>a <strong>substitute for basal insulin. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It is the only approved inhalational insulin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> correct. Afrezza</strong> is currently the only <strong>inhalational insulin</strong> approved by the <strong>FDA.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is used before meals to control postprandial hyperglycemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>correct</strong>.<strong> Afrezza</strong> is a <strong>rapid-acting insulin</strong> taken at the<strong> beginning of a meal</strong> to <strong>control blood sugar spikes after eating.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It should be avoided in chronic smokers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>correct. Afrezza is contraindicated</strong> in patients who <strong>smoke or</strong> have <strong>recently stopped smoking </strong>because of the <strong>risk </strong>of<strong> acute bronchospasm.</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Educational Objective:</u></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhaled insulin (Afrezza) </strong>is an innovative <strong>rapid-acting insulin </strong>administered <strong>before meals</strong> to manage <strong>postprandial hyperglycemia, </strong>but it is<strong> not</strong> a <strong>full substitute for injectable insulin,</strong> especially in terms of providing <strong>basal insulin coverage.</strong></span></span></p>",
      "correct_choice_id": 16927,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4117,
      "choices": [
        {
          "id": 16447,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Age.</span></span></p>"
        },
        {
          "id": 16448,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erosive esophagitis.</span></span></span></p>"
        },
        {
          "id": 16449,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver disease.</span></span></span></p>"
        },
        {
          "id": 16450,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid disease.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old female has been diagnosed with postmenopausal osteoporosis. She has a past medical history of ethanol abuse, alcoholic liver disease, erosive esophagitis, and hypothyroidism. Which of the following would be the primary reason oral bisphosphonates should be used with caution in this patient?</span></span></span></p>",
      "unique_key": "Q9941177",
      "question_audio": null,
      "question_video": null,
      "map_id": 36091,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Erosive esophagitis</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bisphosphonates </strong>are medications used to <strong>prevent the loss of bone mass. </strong>They can cause <strong>esophageal irritation and exacerbate pre-existing esophagitis.</strong> In patients with<strong> erosive esophagitis, </strong>the <strong>use of oral bisphosphonates</strong> <strong>can worsen their condition</strong>, leading to <strong>increased esophageal damage and discomfort</strong>. Therefore, they should be used with<strong> caution or avoided in such cases.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Age:</strong> While the <strong>incidence of osteoporosis increases with age,</strong> age itself is <strong>not </strong>a reason to use <strong>bisphosphonates with</strong> <strong>caution. </strong>These medications are actually often <strong>indicated</strong> to manage<strong> osteoporosis in older adults.</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Liver disease:</strong> Liver disease is<strong> not a direct contraindication for the use of bisphosphonates.</strong> These drugs are primarily <strong>cleared by the kidneys</strong>, so <strong>liver impairment does not typically impact their use or dosing.</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Thyroid disease:</strong> Thyroid disease, <strong>specifically hypothyroidism,</strong> is <strong>not a contraindication for bisphosphonate</strong> therapy. However, <strong>thyroid hormone levels </strong>should be managed appropriately as <strong>thyroid dysfunction can influence bone metabolism.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oral bisphosphonates </strong>should be<strong> used with caution in patients with a history of erosive esophagitis</strong> due to the <strong>risk of esophageal</strong> <strong>irritation and potential exacerbation of the esophageal condition.</strong></span></span></span></span></span></span></p>",
      "correct_choice_id": 16448,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4266,
      "choices": [
        {
          "id": 17041,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></span></span></p>"
        },
        {
          "id": 17042,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Betamethasone</span></span></span></p>"
        },
        {
          "id": 17043,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triamcinolone</span></span></span></p>"
        },
        {
          "id": 17044,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prednisolone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following steroids have selective action on glucocorticoid receptors except?</span></span></span></p>",
      "unique_key": "Q3112938",
      "question_audio": null,
      "question_video": null,
      "map_id": 36083,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Prednisolone</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Prednisolone</strong> exhibits both <strong>glucocorticoid and mineralocorticoid activities</strong>, unlike the other options listed which<strong> primarily exert</strong> effects through <strong>glucocorticoid receptors</strong>. Prednisolone&#39;s ability to act on <strong>both types of receptors means i</strong>t has a broader range of effects, impacting <strong>not only inflammation and immune response</strong>s but also<strong> electrolyte and fluid balance</strong>. This<strong> dual activity </strong>can influence its<strong> side effect profile and clinical use,</strong> particularly in conditions where <strong>mineralocorticoid effects </strong>are either<strong> undesirable or</strong> need to be <strong>carefully managed.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Dexamethasone</strong>, <strong>B.</strong> <strong>Betamethasone</strong>, <strong>and C.</strong> <strong>Triamcinolone</strong> are noted for their <strong>high glucocorticoid activity </strong>with <strong>minimal to</strong> <strong>no mineralocorticoid effects.</strong> These<strong> steroids</strong> are particularly useful when <strong>strong anti-inflammatory action</strong> is needed without the accompanying<strong> salt and water retention</strong> that can accompany <strong>mineralocorticoid activity.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/03/picture3.jpg\" style=\"height:611px; width:1000px\" /></p>",
      "correct_choice_id": 17044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}